Unichem Pharmaceuticals USA Inc. FDA Inspection Record
Unichem Pharmaceuticals USA Inc. is an FDA-inspected facility (FEI 3015297395) located in East Brunswick, NJ, US. RegDataLab tracks 1 FDA inspection at this facility.
What FDA found at this site
- Latest inspection
- Sep 21, 2023: No Action Indicated (NAI)
- Inspections on record
- 1 (1 NAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Recalls as the recalling firm
- 9, latest Oct 30, 2026
- Import refusals
- 1
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Sep 21, 2023 | No Action Indicated (NAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Oct 30, 2026 | Class II | D-0183-2027 | Amiodarone Hydrochloride Tablets, USP, 200 mg, 60 Tablets per bottle, Rx Only… Presence of Foreign Substance |
| Apr 13, 2026 | Class III | D-0511-2026 | busPIRone Hydrochloride Tablets, USP, 5 mg, 500-count bottle, Rx Only, Manufactured by… Subpotent drug |
| Jan 21, 2026 | Class II | D-0301-2026 | Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count… cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits. |
| Jan 21, 2026 | Class III | D-0306-2026 | Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem… Tablets/Capsules Imprinted with Wrong ID |
| Aug 27, 2025 | Class I | D-0655-2025 | Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, 90-count bottle, RX only… Labeling: Label Mix Up; Bottles of Meloxicam USP, 7.5mg, 90-count tablets (yellow in color), were labeled as Cyclobenzaprine Hydrochloride… |
| Sep 19, 2022 | Class III | D-1541-2022 | Clonidine Hydrochloride Tablets, USP, 0.3 mg, 100-count bottle, Rx Only, Manufactured by… Product mix-up:0.2 mg strength Clonidine Hydrochloride Tablets, USP in a 100-count bottle of 0.3 mg strength Clonidine Hydrochloride… |
| Oct 25, 2021 | Class III | D-0255-2022 | Topiramate Tablets, USP 50 mg, 500-count bottles, Rx Only, Manufactured by: Unichem… Discoloration |
| May 26, 2020 | Class III | D-1291-2020 | Clonidine Hydrochloride Tablets, USP 0.1 mg 100-count bottles, Rx only, Manufactured by… Failed Impurities/Degradation Specifications: potential migration of benzophenone at very low level into the product from container. |
| Jan 29, 2020 | Class III | D-0829-2020 | Clonidine Hydrochloride Tablets, USP 0.1mg, Rx Only, 100-count bottle, Manufactured by… Failed Impurities/Degredation Specifications: This recall is initiated as a precautionary measure due to potential migration of Benzophenone… |
FDA record score
23 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
3 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Class I recall D-0655-2025, this FEI as the recalling firm | Aug 27, 2025 | 15 x 1 | 15 |
| Class II recall D-0183-2027, this FEI as the recalling firm | Oct 30, 2026 | 4 x 1 | 4 |
| Class II recall D-0301-2026, this FEI as the recalling firm | Jan 21, 2026 | 4 x 1 | 4 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing Unichem Pharmaceuticals USA Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Unichem Pharmaceuticals USA Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Unichem Pharmaceuticals USA Inc.
- Location
- East Brunswick, NJ (US)
- Source
- inspections